Generic Name: japanese enceph vacc sa14-14-2, inactivated
Applies to japanese enceph vacc sa14-14-2, inactivated: parenteral suspension for im use
Side effects include:
Infants and children 2 months through 11 years of age: Fever, irritability, flu-like symptoms, diarrhea, vomiting, loss of appetite, rash, injection site reactions (pain, tenderness, erythema). 
Adults and adolescents â‰¥12 years of age: Headache, myalgia, fatigue, influenza-like illness, nausea, injection site reactions (pain, tenderness, erythema, induration). 
Applies to japanese enceph vacc sa14-14-2, inactivated: intramuscular suspension
Nervous system side effects have included headache.[Ref]
Musculoskeletal side effects have included myalgia and back pain.[Ref]
Local side effects have included pain, tenderness, pruritus, erythema, induration, and edema.[Ref]
Respiratory side effects have included nasopharyngitis, rhinitis, upper respiratory tract infection, pharyngolaryngeal pain, and cough.[Ref]
Gastrointestinal side effects have included nausea, diarrhea, and vomiting.[Ref]
General side effects have included fatigue, influenza-like illness, and pyrexia.[Ref]
Dermatologic side effects have included rash.[Ref]
1. "Product Information. Ixiaro (Japanese encephalitis virus vaccine SA14-14-2)." Novartis Pharmaceuticals, East Hanover, NJ. 
Not all side effects for Ixiaro may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
